Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
95
datasets available to search
ShareScore release 0.9.0
Dataset results
95 results for “Lymphoma cancer”
Lymphoma B cells remodel bone marrow stromal cell network into extracellular matrix-producing cancer-associated fibroblasts (scRNAseq)
GEO Series GSE271805. Mus musculus. 4 samples. Type: Expression profiling by high throughput sequencing.
Targeting T-cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune Modulatory Signaling Pathways
GEO Series GSE148069. Homo sapiens. 32 samples. Type: Expression profiling by high throughput sequencing.
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
ClinicalTrials.gov study NCT07069699. IPD Sharing: YES. Countries: 1. Publications: 0.
Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib
ClinicalTrials.gov study NCT05948462. IPD Sharing: NO. Countries: 1. Publications: 0.
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer
ClinicalTrials.gov study NCT00006019. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas
ClinicalTrials.gov study NCT00647764. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00848601. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of TQ-B3139 in Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib
ClinicalTrials.gov study NCT04056572. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study
ClinicalTrials.gov study NCT04396119. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Learn More About Copanlisib Treatment Patterns in People With Indolent Non-Hodgkin Lymphoma, a Type of Cancer That Grows and Spread Slowly and Develops in the Lymphatic System (a Part of Im
ClinicalTrials.gov study NCT05217914. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Efficacy and Safety of Alectinib in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03155009. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea
ClinicalTrials.gov study NCT03271554. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exercise and Tumor Blood Flow in Lymphoma And Breast Cancer Patients (EXETUMOR 3)
ClinicalTrials.gov study NCT04990856. IPD Sharing: YES. Countries: 1. Publications: 0.
Immunodeficiency and Cancer: Identification of Congenital Immune System Defects Underlying Paediatric Lymphomas
ClinicalTrials.gov study NCT06332196. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (
ClinicalTrials.gov study NCT04970901. IPD Sharing: NO. Countries: 6. Publications: 0.
The Leukemia and Lymphoma Society (LLS) T-cells in Blood Cancer and COVID-19
ClinicalTrials.gov study NCT04898985. IPD Sharing: NO. Countries: 1. Publications: 0.
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
ClinicalTrials.gov study NCT00004241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
ClinicalTrials.gov study NCT03194893. IPD Sharing: YES. Countries: 9. Publications: 0.
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT06015880. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas
ClinicalTrials.gov study NCT01555242. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.